2 results match your criteria: "Aichi Medical University School of Medicine and Hospital[Affiliation]"
Factors associated with early discontinuation of anamorelin in patients with cancer-associated cachexia.
Support Care Cancer
October 2023
Department of Palliative and Supportive Medicine, Graduate School of Medicine, Aichi Medical University, Nagakute, Japan.
Purpose: Cancer-associated cachexia, a multifactorial syndrome involving loss of muscle mass and anorexia, is an unremitting problem for cancer patients. Anamorelin has become available for cancer-associated cachexia, but early discontinuation is common in clinical practice. This study aimed to explore factors related to the early discontinuation of anamorelin and its relationship to survival.
View Article and Find Full Text PDFConsiderations about the Use of a Loading Dose of Daptomycin in a Neutropenic Murine Thigh Infection Model with Methicillin-Resistant Staphylococcus aureus Infection.
Chemotherapy
March 2018
Department of Infection Control and Prevention, Aichi Medical University School of Medicine and Hospital, Nagakute, Japan.
Previous clinical studies have showed the clinical benefits of the initiation of treatment with a daptomycin (DAP) loading dose, but only a few studies have evaluated its antimicrobial benefits. We evaluated the efficacy of a DAP loading dose against methicillin-resistant Staphylococcus aureus (MRSA) infections in a neutropenic murine thigh infection model. Three MRSA isolates (DAP MIC: 0.
View Article and Find Full Text PDF